Advertisement

Mundipharma International Ltd Company Profile

11:31 EDT 19th June 2013 | BioPortfolio

The Mundipharma International Group of Companies are privately owned associated companies and joint ventures covering the world’s pharmaceutical markets. The Group is particularly strong in analgesics, respiratory products, cardiovascular medicines, antiseptics and laxatives.We employ over 4000 people and have ex-company sales of over $800m of which 25% are from licensed products. Total sales of products developed by our Group are in excess of $1 billion. We have research and production centres in the US (Purdue Pharma), UK (Napp Pharmaceuticals), Canada (Purdue Frederick) and Germany (Mundipharma) and through our joint ventures in India, China, Latin America and Cyprus.

Mundipharma International is seeking to license projects at various stages of clinical development in the following therapeutic areas:

Analgesics and anaesthetics,

Cardiovascular,

Inflammation,

Metabolic diseases,

Oncology,

Palliative care including laxatives,

Respiratory,

Urinary incontinence

Location

Cambridge Science Park
Cambridge
Cambridgeshire
CB4 0GW
United Kingdom

Contact

Phone: 01223 424211
Fax: 01223 426626


News Articles [ 29 Associated News Articles listed on BioPortfolio]

[Mundipharma] licenses blood cancer compounds from [Northlake]; could pay up to $84.5mm

In a deal that could be worth up to $84.5mm, one-year old drug development firm [Northlake International LLC] has granted [Mundipharma International Ltd.] (cancer, pain, respiratory, and gastrointesti...

Infinity restructures deal with Mundipharma, Purdue

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) restructured a 2008 deal with Purdue Pharma L.P. (Stamford, Conn.) and its affiliate Mundipharma International Ltd. (Cambridge, U.K.) for Infinity's phospho...

Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin lymphoma and MCL patients

Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line treatment regimen of bendamustine (marketed under the trade name Levact by privately-held Swiss dru...

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue

USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with Swiss privately-held Mundipharma International and Purdue Pharmaceutical Products by mutual agree...

PI3K and mix: Infinity gets back assets and cash from Mundipharma

In an effort to retain more value from its phosphoinositide-3-kinase (PI3K), fatty acid amide hydrolase (FAAH) and early discovery programs, Infinity Pharmaceuticals traded its partnership with UK-bas...

Northlake, Mundipharma collaborate to develop alkylating agents

Mundipharma and Northlake International have joined forces to develop structurally new next generation alkylating agents to treat haematological malignancies.

Infinity, Mundipharma, Purdue Pharma deal

Mundipharma, SkyePharma sales and marketing update

Drugs and Medications [ 423 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Pdi sani-hands for kids [Professional Disposables International, Inc.]

PDI SANI-HANDS FOR KIDS ANTIMICROBIAL ALCOHOL GEL HAND WIPES

PubMed Articles [ 4 Associated PubMed Articles listed on BioPortfolio]

Response to the Letter to the Editor by Dr. Srinivas on the recent publication of Al-Tawil et al. on the pharmacokinetics of transdermal buprenorphine patch in the elderly.

Low absolute bioavailability of oral naloxone in healthy subjects.

Objective: To determine the absolute bioavailability of naloxone from oral doses ranging from 5 mg to 120 mg. Materials and methods: In this open-label study, 28 healthy subjects received naloxone 1 m...

Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers.

Objectives: This exploratory study in healthy volunteers investigated the effect of single doses of oxycodone on gastrointestinal (GI) transit time and the degree to which a single dose of naloxone re...

The Direct and Indirect Costs of Opioid-Induced Constipation.

CONTEXT: Treatment with strong opioids is connected with frequent and problematic side effects. One of the most common side effects is opioid-induced constipation (OIC). The discomfort of OIC can limi...

Clinical Trials [ 342 Associated Clinical Trials listed on BioPortfolio]

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial...

INTERSALT: International Study of Sodium, Potassium, and Blood Pressure

To coordinate an international study on the relationships between population mean sodium and potassium intake and blood pressure.

The Von Willebrand Disease (VWD) International Prophylaxis Study

The von Willebrand Disease Prophylaxis Network (vWD PN) is an international study group formed with the goal of investigating the role of prophylaxis in clinically severe VWD that is non-r...

International Programs Collaborative Studies Coordinating Center

To continue the work of the Collaborative Studies Coordinating Center (CSCC) on international studies in cardiopulmonary disease epidemiology. The work was being performed under bilateral...

Companies [ 1079 Associated Companies listed on BioPortfolio]

Mundipharma International Ltd

The Mundipharma International Group of Companies are privately owned associated companies and joint ventures covering the world’s pharmaceutical markets. The Group is particularly strong in analgesi...

Mundipharma International Limited

Nil

Mundipharma

Novelos Therapeutics, Inc.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Novelos is seeking to bui...

International Science and Technology Center (ISTC)b

The International Science and Technology Center (ISTC) was established by international agreement in November 1992 as a nonproliferation program.The ISTC coordinates the efforts of numerous government...

More Information about "Mundipharma International Ltd" on BioPortfolio

We have published hundreds of Mundipharma International Ltd news stories on BioPortfolio along with dozens of Mundipharma International Ltd Clinical Trials and PubMed Articles about Mundipharma International Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mundipharma International Ltd Companies in our database. You can also find out about relevant Mundipharma International Ltd Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement